Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas.
CONCLUSION: Our findings showed that concomitant expression of CSC markers CD133/CXCR4 might had a synergistic effect on the OS poor prognosis. These markers could be considered as potential therapeutic candidates of OS targeted therapy.<br />.
PMID: 31983166 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Osteosarcoma | Stem Cell Therapy | Stem Cells | Study